Use of antiretrovirals is associated to body fat accumulation. We measured body composition in adolescents living with HIV switched to a dolutegravir-containing regimen. Trunk fat and trunk/body fat ratio markedly increased after 12 months. Total and low density lipoprotein cholesterol decreased after 3 months. Increase in trunk fat may put at risk of future cardiovascular problems, despite improvement in the lipid profile.
Body Fat Distribution and Metabolic Changes in a Cohort of Adolescents Living With HIV Switched to an Antiretroviral Regimen Containing Dolutegravir / V. Giacomet, S. Lazzarin, A. Manzo, L. Paradiso, K. Maruca, G. Barera, G.V. Zuccotti, S. Mora. - In: THE PEDIATRIC INFECTIOUS DISEASE JOURNAL. - ISSN 0891-3668. - 40:5(2021), pp. 457-459. [10.1097/INF.0000000000003066]
Body Fat Distribution and Metabolic Changes in a Cohort of Adolescents Living With HIV Switched to an Antiretroviral Regimen Containing Dolutegravir
V. GiacometPrimo
;S. LazzarinSecondo
;L. Paradiso;G.V. ZuccottiPenultimo
;
2021
Abstract
Use of antiretrovirals is associated to body fat accumulation. We measured body composition in adolescents living with HIV switched to a dolutegravir-containing regimen. Trunk fat and trunk/body fat ratio markedly increased after 12 months. Total and low density lipoprotein cholesterol decreased after 3 months. Increase in trunk fat may put at risk of future cardiovascular problems, despite improvement in the lipid profile.File | Dimensione | Formato | |
---|---|---|---|
Body_Fat_Distribution_and_Metabolic_Changes_in_a.15.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
433.02 kB
Formato
Adobe PDF
|
433.02 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.